These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9330636)

  • 21. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor.
    Garkavtsev I; Riabowol K
    Mol Cell Biol; 1997 Apr; 17(4):2014-9. PubMed ID: 9121449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
    Cheung KJ; Mitchell D; Lin P; Li G
    Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
    Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I
    Cancer Res; 1997 Apr; 57(7):1255-8. PubMed ID: 9102209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.
    Scott M; Boisvert FM; Vieyra D; Johnston RN; Bazett-Jones DP; Riabowol K
    Nucleic Acids Res; 2001 May; 29(10):2052-8. PubMed ID: 11353074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p33(ING1) enhances UVB-induced apoptosis in melanoma cells.
    Cheung KJ; Li G
    Exp Cell Res; 2002 Oct; 279(2):291-8. PubMed ID: 12243754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities.
    Loewith R; Meijer M; Lees-Miller SP; Riabowol K; Young D
    Mol Cell Biol; 2000 Jun; 20(11):3807-16. PubMed ID: 10805724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function.
    Zeremski M; Hill JE; Kwek SS; Grigorian IA; Gurova KV; Garkavtsev IV; Diatchenko L; Koonin EV; Gudkov AV
    J Biol Chem; 1999 Nov; 274(45):32172-81. PubMed ID: 10542254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
    Cheung KJ; Bush JA; Jia W; Li G
    Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity.
    Ohgi T; Masaki T; Nakai S; Morishita A; Yukimasa S; Nagai M; Miyauchi Y; Funaki T; Kurokohchi K; Watanabe S; Kuriyama S
    Scand J Gastroenterol; 2002 Dec; 37(12):1440-8. PubMed ID: 12523595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.
    Igci M; Arslan A; Erturhan S; Igci YZ; Pala E; Gogebakan B; Karakok M; Cakmak EA; Cengiz B
    Mol Biol Rep; 2015 Feb; 42(2):507-16. PubMed ID: 25324173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ING1 and ING2: multifaceted tumor suppressor genes.
    Guérillon C; Larrieu D; Pedeux R
    Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative levels of alternative transcripts of the ING1 gene and lack of mutations of p33/ING1 in haematological malignancies.
    Bromidge T; Lynas C
    Leuk Res; 2002 Jul; 26(7):631-5. PubMed ID: 12008079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different HATS of the ING1 gene family.
    Feng X; Hara Y; Riabowol K
    Trends Cell Biol; 2002 Nov; 12(11):532-8. PubMed ID: 12446115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p33ING1b and estrogen receptor (ER) alpha.
    Toyama T; Iwase H
    Breast Cancer; 2004; 11(1):33-7. PubMed ID: 14718790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex.
    Skowyra D; Zeremski M; Neznanov N; Li M; Choi Y; Uesugi M; Hauser CA; Gu W; Gudkov AV; Qin J
    J Biol Chem; 2001 Mar; 276(12):8734-9. PubMed ID: 11118440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.
    Goeman F; Thormeyer D; Abad M; Serrano M; Schmidt O; Palmero I; Baniahmad A
    Mol Cell Biol; 2005 Jan; 25(1):422-31. PubMed ID: 15601862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
    Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
    Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.